Dual character of surface engineering on SN38 prodrug nano-assemblies: divergent effects on in vitro and in vivo behavior
RESEARCH|Updated:2025-10-14
|
Dual character of surface engineering on SN38 prodrug nano-assemblies: divergent effects on in vitro and in vivo behavior
“In the realm of nanomedicine, a study has made strides by examining the impact of PEGylation levels on the performance of SN38 prodrug nanoparticles. Expert researchers systematically evaluated varying PEGylation levels, which significantly influence stability, drug release, cytotoxicity, and antitumor efficacy. High PEGylation at 150% NPs demonstrated superior antitumor effects and minimal intestinal toxicity, offering a promising solution for enhancing the delivery and safety of chemotherapy drugs.”
Military Medical ResearchVol. 12, (2025)
Affiliations:
1.Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China
2.Department of Bioengineering, Graduate School of Engineering, the University of Tokyo, Tokyo 113-0033, Japan
3.Department of Pharmacy, the First Affiliated Hospital of Jinzhou Medical University, Jinzhou 121001, Liaoning, China
4.State Key Laboratory of Antiviral Drugs, School of Pharmacy, Henan University, Kaifeng 475004, Henan, China
5.Joint International Research Laboratory of Intelligent Drug Delivery Systems, Ministry of Education, Shenyang 110016, China
Ya-Qiao Li, Zhi-Yu Kuang, Bao-Yuan Zhang, et al. Dual character of surface engineering on SN38 prodrug nano-assemblies: divergent effects on in vitro and in vivo behavior[J/OL]. Military Medical Research, 2025, 12.
DOI:
Ya-Qiao Li, Zhi-Yu Kuang, Bao-Yuan Zhang, et al. Dual character of surface engineering on SN38 prodrug nano-assemblies: divergent effects on in vitro and in vivo behavior[J/OL]. Military Medical Research, 2025, 12. DOI: 10.1186/s40779-025-00648-6.
Dual character of surface engineering on SN38 prodrug nano-assemblies: divergent effects on in vitro and in vivo behavior